Comparison of Excitatory Amino Acid-Stimulated Phosphoinositide Hydrolysis and N-[3H]Acetylaspartylglutamate Binding in Rat Brain: Selective Inhibition of Phosphoinositide Hydrolysis by 2-Amino-3-Phosphonopropionate-Reference-Cited by-同舟云学术

Comparison of Excitatory Amino Acid-Stimulated Phosphoinositide Hydrolysis and N-[3H]Acetylaspartylglutamate Binding in Rat Brain: Selective Inhibition of Phosphoinositide Hydrolysis by 2-Amino-3-Phosphonopropionate

Published:1989-07 Issue:1 Volume:53 Page:273-278
ISSN:0022-3042
Container-title:Journal of Neurochemistry
language:en
Short-container-title:J Neurochem

Author:

Schoepp Darryle D.,Johnson Bryan G.

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience,Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1471-4159.1989.tb07324.x/fullpdf

Reference23 articles.

1. Dipeptides of glutamate and aspartate may be endogenous neuroexcitants in the rat hippocampal slice

2. A re-examination of the interaction of N-acetyl-L-aspartyl-L-glutamate with a subpopulation of rat brain membrane L-[3H]glutamate binding sites

3. Characterization of the binding of dl-[3H]-2-amino-4-phosphonobutyrate to l-glutamate-sensitive sites on rat brain synaptic membranes

4. 2-Amino-5-phosphonovalerate (2APV), a potent and selective antagonist of amino acid-induced and synaptic excitation

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glutamate receptors and synaptic plasticity: The impact of Evans and Watkins;Neuropharmacology;2022-03

2. Development of Biologically Active Compounds on the Basis of Phosphonic and Phosphinic Acid Functionalities;YAKUGAKU ZASSHI;2017-09-01

3. Chiral Sulfinimines in Asymmetric Synthesis of Enantiomeric Aminophosphonic Acids;Phosphorus, Sulfur, and Silicon and the Related Elements;2014-08-03

4. Asymmetric Synthesis of Structurally Diverse Aminophosphonic Acids by Using Enantiopure N-(p-Tolylsulfinyl)cinnamaldimines as Reagents;EUR J ORG CHEM;2013

5. Metabotropic glutamate receptors: From the workbench to the bedside;Neuropharmacology;2011-06